AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionSowell Financial Services LLC
Latest Disclosed Ownership44,813 shares
Latest Disclosed Value $ 9,746,278
Sowell Financial Services LLC reports 5.59% decrease in ownership of 4AB / AbbVie Inc.

On April 20, 2026 - Sowell Financial Services LLC filed a 13F-HR form disclosing ownership of 44,813 shares of AbbVie Inc. (DE:4AB) valued at $8,308,330 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 47,464 shares of AbbVie Inc.. This represents a change in shares of -5.59% during the quarter. The current value of the position is $8,447,250 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ABBVIE COM 00287Y109 44,813 -2,651 -5.59 9,746 -10.13 0.3604
2026-01-21 2025-12-31 13F ABBVIE COM 00287Y109 47,464 -5,761 -10.82 10,845 -11.99 0.3984
2025-10-17 2025-09-30 13F ABBVIE COM 00287Y109 53,225 -8,716 -14.07 12,324 7.18 0.4729
2025-07-14 2025-06-30 13F ABBVIE COM 00287Y109 61,941 -1,610 -2.53 11,498 -13.65 0.4683
2025-04-17 2025-03-31 13F ABBVIE COM 00287Y109 63,551 4,979 8.50 13,315 27.93 0.6060
2025-02-07 2024-12-31 13F ABBVIE COM 00287Y109 58,572 746 1.29 10,408 -8.85 0.5474
2024-10-04 2024-09-30 13F ABBVIE COM 00287Y109 57,826 -3,959 -6.41 11,419 7.76 0.5305
2024-08-13 2024-06-30 13F ABBVIE COM 00287Y109 61,785 2,500 4.22 10,597 -1.84 0.5060
2024-05-03 2024-03-31 13F ABBVIE COM 00287Y109 59,285 -498 -0.83 10,796 16.52 0.5092
2024-01-24 2023-12-31 13F ABBVIE COM 00287Y109 59,783 -1,510 -2.46 9,265 1.41 0.5019
2023-11-08 2023-09-30 13F ABBVIE COM 00287Y109 61,293 2,498 4.25 9,136 15.34 0.5734
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 58,795 16,027 37.47 7,921 131,916.67 0.4415
2023-05-12 2023-03-31 13F ABBVIE STOCK 00287Y109 42,768 -15,438 -26.52 7 -33.33 0.5259
2023-02-09 2022-12-31 13F Abbvie Stock 00287Y109 58,206 15,067 34.93 9 -99.84 0.6089
2022-11-15 2022-09-30 13F Abbvie Stock 00287Y109 43,139 -1,540 -3.45 5,790 -15.39 0.5838
2022-08-15 2022-06-30 13F ABBVIE Stock 00287Y109 44,679 26,537 146.27 6,843 134.35 0.6325
2022-05-13 2022-03-31 13F ABBVIE Stock 00287Y109 18,142 -22,167 -54.99 2,920 -46.50 0.5101
2022-02-09 2021-12-31 13F ABBVIE INC COM Stock 00287Y109 40,309 -11,540 -22.26 5,458 -2.41 0.3130
2021-11-04 2021-09-30 13F ABBVIE INC COM Stock 00287Y109 51,849 -35,907 -40.92 5,593 -43.42 0.3777
2021-08-05 2021-06-30 13F ABBVIE INC COM Stock 00287Y109 87,756 -12,031 -12.06 9,885 -14.66 0.6549
2021-05-07 2021-03-31 13F ABBVIE INC COM Stock 00287Y109 99,787 11,029 12.43 11,583 21.80 0.4032
2021-01-13 2020-12-31 13F ABBVIE INC COM COM 00287Y109 88,758 2,207 2.55 9,510 25.45 0.4063
2020-11-12 2020-09-30 13F ABBVIE INC COM COM 00287Y109 86,551 7,923 10.08 7,581 -1.80 0.3786
2020-08-13 2020-06-30 13F ABBVIE INC COM Stock 00287Y109 78,628 21,662 38.03 7,720 77.88 0.4243
2020-05-12 2020-03-31 13F ABBVIE INC COM Stock 00287Y109 56,966 4,270 8.10 4,340 -6.99 0.3212
2020-02-07 2019-12-31 13F ABBVIE INC COM Stock 00287Y109 52,696 -797 -1.49 4,666 15.21 0.3556
2019-11-14 2019-09-30 13F ABBVIE INC COM COM 00287Y109 53,493 7,805 17.08 4,050 9.99 0.3346
2019-05-15 2019-03-31 13F ABBVIE INC COM Stock 00287Y109 45,688 1,932 4.42 3,682 -8.73 0.4111
2019-03-05 2018-12-31 13F ABBVIE COM 00287Y109 43,756 3,464 8.60 4,034 5.85 0.5714
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 40,292 1,434 3.69 3,811 1.33 0.5533
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 38,858 1,563 4.19 3,761 0.48 0.7982
2018-05-10 2018-03-31 13F ABBVIE COM 00287Y109 37,295 -9,727 -20.69 3,743 -23.31 0.9353
2018-01-29 2017-12-31 13F ABBVIE COM 00287Y109 47,022 -3,373 -6.69 4,881 4.76 1.1934
2017-11-07 2017-09-30 13F ABBVIE COM 00287Y109 50,395 -2,934 -5.50 4,659 22.25 1.2147
2017-08-14 2017-06-30 13F ABBVIE COM 00287Y109 53,329 -1,364 -2.49 3,811 5.68 1.0817
2017-05-31 2017-03-31 13F ABBVIE COM 00287Y109 54,693 1,151 2.15 3,606 10.75 1.0648
2017-02-27 2016-12-31 13F Abbvie Inc Com COM 00287Y109 53,542 53,542 3,256 1.0902
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.